Akt levels are decreased in the striatum of patients with HD and, in parallel, the caspase-3-cleaved 49 kDa Akt product has been observed in the cerebellum and the cortex of HD patients [87], suggesting that the caspase-3 protease is activated in patients with HD [39]. This evidence concerns the gene AKT1 and Huntington disease.